Tripletail Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-228
Closed -$14.2K – 279
2026
Q1
$14.2K Hold
228
– – 0.02% 200
2025
Q4
$15.1K Hold
228
– – 0.02% 196
2025
Q3
$15.2K Buy
+228
New +$18K 0.02% 241

Other funds holding DXCM

Tripletail Wealth Management's DXCM Position: Q2 2026 in Review

Tripletail Wealth Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 228 shares — an estimated $14.2K sold.

Tripletail Wealth Management first reported a position in DXCM in Q3 2025 and held it in 3 quarters. The position peaked at $15.2K in Q3 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Tripletail Wealth Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Tripletail Wealth Management sold 228 DexCom shares in Q2 2026, an estimated $14.2K.
  • Tripletail Wealth Management first reported a position in DexCom in Q3 2025 and held it in 3 quarters.
  • Tripletail Wealth Management's DexCom position peaked at $15.2K in Q3 2025.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Tripletail Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.